COL1A1 and metabolic dysfunction-associated steatohepatitis: We further confirmed the results using Western blot, and our results showed that CM prevented the upregulation of fibrosis markers such as Fibronectin, Col1a1, and CTGF induced by the NASH diet (Figure 8C).